by Calvin Freiburger, LifeSite News:
TRUTH LIVES on at https://sgtreport.tv/
Dr. Patrick Soon-Shiong is a billionaire who pioneered the cancer drug Abraxane and has owned and led multiple medical companies. In 2018, he purchased the Los Angeles Times (which he blocked from endorsing Democrat Kamala Harris for president in 2024), and his ImmunityBio was among the companies recruited by the Trump administration to contribute to Operation Warp Speed.
On Tuesday, Soon-Shiong appeared on the 2WAY podcast, where he shared his thoughts about some of the big medical policy questions of the next four years.
🚨Dr. Patrick Soon-Shiong, owner of the LA Times and a renowned transplant surgeon, is raising alarms about the fallout from mRNA COVID-19 “vaccines,” linking them to unprecedented deaths and cancers in children.
“For the first time in my career, I’ve seen an 8-year-old,… pic.twitter.com/G9kFaPwQ3e
— Steven Miller, MD, PhD (@SageListener) January 14, 2025
“I think people misunderstand Bobby Kennedy, Robert F. Kennedy. He’s really all about the science,” he said. “I’ve sat down with him, met with him for the first time. I’ve not known him until I sat down with him, because I wanted to understand what he was thinking. And after hours of sitting down with him, I was so impressed. He knows more about the science than most doctors.”
Soon-Shiong went on to say “we’re going to have to address the rising incidence of cancer. For the first time in my career, I’ve seen an 8-year-old, 9-year-old, 10-year-old with colon cancer. The first time in my career, I’ve had a 13-year-old child in our clinic die of metastatic pancreatic cancer. We have to face this effectiveness and reality.”
The doctor ended on an optimistic note, saying that “there are effective therapies because we understand the science in such an immense way,” and adding that he is “excited about this next four years of bringing this information across and not to scare the population to say, look, we could lead the world in our innovation and using healthcare as a foreign policy around the world.”
